Cisatracurium Besylate
Active substance: cisatracurium
INJECTION, SOLUTION · CISATRACURIUM BESYLATE 10 mg/mL
United StatesActive
Marketing holder: Hospira, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CISATRACURIUM BESYLATE · 10 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2cf8-7f48-9dd6-d0995f2d77e5,01a1208c-3c21-73a8-95da-af64e729a953,01a1208c-58f8-7865-ade5-c9b13001c39a,01a1208c-b4cd-7792-a5f7-7b0f2e731661,01a1208c-c1de-79c4-bb37-260278eedca0;count=38 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0409-1103
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0409-1103 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0409-1103 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0409-1103 · Verified 2026-10-09 · open in source